Year: 2004
Type: review
Abstract: The adaptive phase of the immune response begins with engagement on CD4+ helper T cells of the T cell antigen receptor (TCR)1 by its ligand, a small foreign peptide bound to a cell surface protein of the class II major histocompatibility complex (peptide-MHC) expressed on an antigen-presenting cell. This engagement initiates a series of biochemical events that can differentially signal the naive T cell to: 1) enter into a pathway leading to generation of effector T cells with the onset of rapid proliferation and production of effector cytokines; 2) enter into a state of antigenic non-responsiveness known as anergy; or 3) die by apoptosis.
Source: Journal of Biological Chemistry
Authors: Yanping Huang, Ronald L. Wange
Institutions: National Institutes of Health, National Institute on Aging
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2092284137
